Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 249-263

  Guyon, Thierry ^a   Wakkach, Abdelilah ^a   Poea, Sandrine ^a   Mouly, Vincent ^b   Klingel Schmitt, Isabelle ^a   Levasseur, Philippe ^a   Beeson, David ^c   Asher, Orna ^d   Tzartos, Socrates ^e   Berrih Aknin, Sonia ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b CNRS   (France)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

Anti AChR monoclonal antibody; Autoimmune disease; Myogenic factors; Quantitative polymerase chain reaction; TE671 muscle cell line

Indexed keywords

CHOLINERGIC RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MYASTHENIA GRAVIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 0032128319     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1248     Document Type: Article

References (73)

1. Raftery, M., M. Hunkapillar, C. Strader, and L. Hood. 1980. Acetylcholine receptor: complex of homologous subunits. Science. 208:1454-1457.
2. Popot, J.L., and J.P. Changeux. 1984. The nicotinic receptor of acetylcholine: structure of an oligomeric integral membrane protein. Physiol. Rev. 64: 1162-1239.
3. Buonanno, A., and J.P. Merlie. 1986. Transcription regulation of the nicotinic acetylcholine receptor gene during muscle development. J. Biol. Chem. 261:11452-11455.
4. Conti-Tronconi, B.M., and M.A. Raftery. 1982. The nicotinic cholinergic receptor: correlation of molecular structure with functional properties. Annu. Rev. Biochem. 51:491-530.
5. Mishina, M., T. Takai, K. Imoto, M. Noda, T. Takahashi, and S. Numa. 1986. Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature. 321:406-411.
6. Shieh, B.H., M. Ballivet, and J. Schmidt. 1988. Acetylcholine receptors synthesis rate and levels of receptor subunit messengers RNAs in chick muscle. Neuroscience. 24:175-187.
7. Olson, E.N. 1990. MyoD family: a paradigm for development. Genes Dev. 4:1454-1461.
8. Davis, R.L., H. Weintraub, and A.B. Lassar. 1987. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 5:987-1000.
9. Wright, W.E., D.A. Sassoon, and V.K. Lin. 1989. Myogenin, a factor regulating myogenesis has a domain homologous to MyoD. Cell. 56:607-617.
10. Braun, T., G. Buschhausen-Denker, E. Bober, E. Tannich, and H.H. Arnold. 1989. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO (Eur. Mol. Biol. Organ.) J. 8:701-709.
11. Rhodes, S.J., and S.F. Konieczny. 1989. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev. 3:2050-2061.
12. Braun, T., E. Bober, G. Buschhausen-Denker, S. Kotz, K.H. Grzeschik, and H.H. Arnold. 1989. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO (Eur. Mol. Biol. Organ.) J. 8:3617-3625.
13. Braun, T., E. Bober, B. Winter, N. Rosenthal, and H.H. Arnold. 1990. Myf6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO (Eur. Mol. Biol. Organ.) J. 9:821-831.
14. Piette, J., J.L. Bessereau, M. Huchet, and J.P. Changeux, 1990. Two adjacent MyoD1 binding sites regulate expression of the acetylcholine receptor α-subunit gene. Nature. 345:353-355.
15. Gilmour, B.P., G.R. Fanger, C. Newton, S.M. Evans, and P.D. Gardner. 1991. Multiple binding sites for myogenic regulatory factors are required for expression of the acetylcholine receptor gamma subunit gene. J. Biol. Chem. 266: 19871-19874.
16. Eftimie, R., H.R. Brenner, and A. Buonanno. 1991. Myogenin and MyoD join a family of skeletal muscle genes regulated by electrical activity. Proc. Natl. Acad. Sci. USA. 88:1349-1353.
17. Lindstrom, J.M., M.L. Seybold, V.A. Lennon, S. Whittingham, and D.D. Duane. 1976. Antibody to acetylcholine receptor in MG: prevalence, clinical correlates and diagnostic value. Neurology. 26:1054-1059.
18. Vincent, A. 1980. Immunology of acetylcholine receptor in relation to myasthenia gravis. Physiol. Rev. 60:756-822.
19. Fambrough, D.M., D.B. Drachman, and S. Satyamurti. 1973. Neuromuscular junction in MG: decreased acetylcholine receptor. Science. 182:293-295.
20. Toyka, K.V., D.R. Drachman, A. Pestronk, and I. Kao. 1975. Myasthenia gravis: passive transfer from man to mouse. Science. 190:397-399.
21. Eymard, B., S. de la Porte, C. Pannier, S. Berrih Aknin, E. Morel, M. Fardeau, J.F. Bach, and J. Koenig. 1988. Effect of myasthenic patient sera on the number and distribution of acetylcholine receptors in muscle and nerve-muscle cultures from rat. Correlations with clinical state. J. Neurol. Sci. 86:41-59.
22. Tzartos, S.J., D. Sophianos, K. Zimmerman, and A. Starzinski-Powitz. 1986. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate. J. Immunol. 136:3231-3238.
23. Richman, D.P., R.L. Wollmann, R.A. Maselli, C.M. Gomez, A.L. Corey, M.A. Agius, and R.H. Fairclough. 1993. Effector mechanisms of myasthenic antibodies. Ann. NY Acad. Sci. 681:264-273.
24. Engel, A.G., K. Sahashi, and G. Fumagalli. 1981. The immunopathology of acquired myasthenia gravis. Ann. NY Acad. Sci. 377:158-174.
25. Barkas, S., J.M. Gabriel, A. Mauron, J. Hughes, B. Roth, C. Alliod, S. Tzartos, and M. Ballivet. 1988. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the α-subunit. J. Biol. Chem. 263:5916-5920.
26. Tzartos, S., A. Kokla, S.L. Walgrave, and B.M. Conli-Tronconi. 1988. Localization of the main immunogenic region of human muscle acetylcholine receptor to residues 67-76 of the a subunit. Proc. Natl. Acad. Sci. USA. 85:2899.
27. Guyon, T., P. Levasseur, F. Truffault, C. Cottin, C. Gaud, and S. Berrih-Aknin. 1994. Regulation of acetylcholine receptor α-subunit variants in human myasthenia gravis. Quantification of steady-state levels of messenger RNA in muscle biopsy using the polymerase chain reaction. J. Clin. Invest. 94:16-24.
28. Morel, E., F. Raimond, C. Goulon-Goeau, S. Berrih, B. Vernet der Garabedian, J. Harb, and J.F. Bach. 1982. Le dosage des anticorps antirécepteurs de l'acétylcholine dans la myasthénie. Etude de 329 sérums. Nouv. Presse Méd. 11:1849-1854.
29. Perlo, V.P., D.C. Poskanzer, R.S. Schwab, H.R. Viets, K.E. Osserman, and G. Genkins. 1966. Myasthenia gravis: evaluation of treatment in 1355 patients. Neurology. 16:431-439.
30. Levine, G.D., and J. Rosai. 1978. Thymic hyperplasia and neoplasia: a review of current concepts. Hum. Pathol. 9:495-515.
31. Joo, F., G. Savay, and B. Csillik. 1965. A new modification of the Koelle-Friedenwald method for the histochemical demonstration of cholinesterase activity. Acta. Histocheni. 22:40-45.
32. Edom, F., V. Mouly, J.P. Barbet, M.Y. Fiszman, G.S. Butler-Browne. 1994. Clones of human satellite cells can express in vitro both fast and slow myosin heavy chain. Dev. Biol. 164:219-229.
33. Sophianos, D., and S.J. Tzartos. 1989. Fab fragments of monoclonal antibodies protect the human acetylcholine receptor against antigenic modulation caused by myasthenia gravis. J. Autoimmun. 2:777-789.
34. Tzartos, S.J., D.E. Rand, B.E. Einarson, and J.M. Lindstrom. 1981. Mapping of surface structures of electrophorus AChR using monoclonal antibodies. J. Biol. Chem. 256:8635-8645.
35. Papadouli, I., C. Sakarellos, and S.J. Tzartos. 1993. High-resolution epitope mapping and fine antigenic characterization of the main immunogenic region of the acetylcholine receptor. Improving the binding activity of synthetic analogues of the region. Eur. J. Biochem. 211:227-234.
36. Saedi, M.S., R. Anand, W.G. Conroy, and J. Lindstrom. 1990. Determination of amino acids critical to the main immunogenic region of intact acetylcholine receptors by in vitro mutagenesis. FEBS Lett. 2670:55-59.
37. Tzartos, S.J., L. Langeberg, S. Hochschwender, L. Swanson, and J. Lindstrom. 1986. Characteristics of monoclonal antibodies to denatured torpedo and to native calf AChRs: species, subunit and region specificity. J. Neuroimmunol. 10:235-253.
38. Tzartos, S.J., and M.S. Remoundos. 1992. Precise epitope mapping of monoclonal antibodies to the cytoplasmic side of the acetylcholine receptor alpha subunit-dissecting a potentially myasthenogenic epitope. Eur. J. Biochem. 207:915-922.
39. Beeson, D., M. Brydson, M. Betty, S. Jeremiah, S. Povey, A. Vincent, and J. Newsom-Davis. 1993. Primary structure of the human muscle acetylcholine receptor cDNA cloning of the γ and ∈ subunits. Eur. J. Biochem. 215:224-238.
40. Higuchi, R., B. Krummel, and R.K. Saiki. 1988. A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 16:7351-7367.
41. Asher, O., D. Neumann, and S. Fuchs. 1988. Increased levels of acetylcholine receptor α-subunit mRNA in experimental autoimmune myasthenia gravis. FEBS Lett. 233:277-281.
42. Luther, M.A., R. Schoepfer, P. Whiting, B. Casey, Y. Blatt, M.S. Montal, M. Montal, and J. Lindstrom. 1989. A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosci. 9:1082-1096.
43. Kaminski, H.J., L.L. Kusner, and C.H. Block. 1996. Expression of acetylcholine receptor isoforms at extraocular muscle endplates. Invest. Ophthalmol. Vis. Sci. 37:345-351.
44. Beeson, D., A. Morris, A. Vincent, and J. Newsom-Davis. 1990. The human muscle nicotinic acetylcholine receptor α-subunit exists as two isoforms: a novel exon. EMBO (Eur. Mol. Biol. Organ.) J. 9:2101-2106.
45. Brenner, H.R., V. Witzemann, and B. Sakmann. 1990. Imprinting of acetylcholine receptor messenger RNA accumulation in mammalian neuromuscular synapses. Nature. 344:544-547.
46. Clark, J., P.J. Rocques, T. Braun, E. Bober, H.H. Arnold, C. Fisher, C. Fletcher, K. Brown, B.A. Gusterson, R.L. Carter, and C.S. Cooper. 1991. Expression of members of the Myf gene family in human rhabdomyosarcomas. Br. J. Cancer. 64:1039-1042.
47. Tzartos, S.J., and A. Starzinski-Powitz. 1986. Decrease in acetylcholine receptor content of human myotube cultures mediated by monoclonal antibodies to α, β and γ subunits. FEBS Lett 196:91-95.
48. Conroy, W.G., M.S. Saedi, and J. Lindstrom. 1990. TE671 Cells express an abundance of a partially mature acetylcholine receptor a subunit which has characteristics of an assembly intermediate. J. Biol. Chem. 265:21642-21651.
49. Asher, O., D. Neumann, V. Witzemann, and S. Fuchs. 1990. Acelylcholine receptor gene expression in experimental autoimmune myasthenia gravis. FEBS Lett. 267:231-235.
50. Asher, O., W.A. Kues, V. Witzemann, S.J. Tzartos, S. Fuchs, and M.C. Souroujon. 1993. Increased gene expression of acetylcholine receptor and myogenic factors in passively transferred experimental autoimmune myasthenia gravis. J. Immunol. 151:6442-6450.
51. MacLennan, C., D. Beeson, A.M. Buijs, A. Vincent, and J. Newsom-Davis. 1997. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis. Ann. Neurol. 41:423-431.
52. Hughes, S.M., J.M. Taylor, S.J. Tapscott, C.M. Gurley, W.J. Cater, and C.A. Peterson. 1993. Selective accumulation of MyoD and myogenin mRNAs in fast and slow skeletal muscle is controlled by innervation and hormones. Dev. 118:1137-1147.
53. Martinou, J.C., and J.P. Merlie. 1991. Nerve dependent modulation of acetylcholine receptor ∈-subunit gene expression in muscle. J. Neurosci. 11: 1291-1299.
54. Carraway III, K.L., and L.C. Cantley. 1994. A neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling. Cell. 78:5-8.
55. Altiok, N., J.L. Bessereau, and J.P. Changeux. 1995. ErbB3 and ErbB2/ neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate. EMBO (Eur. Mol. Biol. Organ.) J. 14:4258-4266.
56. Loeb, J., and G.D. Fischbach. 1995. ARIA can he released from extracellular matrix through cleavage of a heparin-binding domain. J. Cell Biol. 130: 127-135.
57. Drachman, D.B. 1994. Myasthenia gravis. N. Engl. J. Med. 330:1797-1810.
58. Plomp, J.J., G.T. Van Kempen, M.B. De Baets, Y.M. Graus, J.B. Kuks, and P.C. Molenaar. 1995. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Ann. Neurol. 37:627-636.
59. Asher, O., S. Fuchs, D. Zuk, D. Rapaport, and A. Buonanno. 1992. Changes in the expression of mRNA for myogenic factors and other muscles specific proteins in experimental autoimmune myasthenia gravis. FEBS Lett. 299:15-18.
60. Goldman, D., H.R. Brenner, and S. Heinemann. 1988. Acetylcholine receplor α, β, γ and δ subunit mRNA levels are regulated by muscle activity. Neuron. 1:329-333.
61. Witzemann, V., H.R. Brenner, and B. Sakmann. 1991. Neural factors regulate nAChR subunit mRNAs at rat neuromuscular synapses. J. Cell Biol. 114:125-141.
62. Adams, L., B.M. Carlson, L. Henderson, and D. Goldman. 1995. Adaptation of nicotinic acetylcholine receptor, myogenin and MRF4 gene expression to long-term muscle denervation. J. Cell. Biol. 131:1341-1349.
63. Lindstrom, J.M., and E.H. Lambert. 1978. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology. 28: 130-138.
64. Pestronk, A., D.B. Drachman, and S.G. Self. 1985. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates. Muscle Nerve. 8:245-251.
65. Klarsfeld, A., and J.P. Changeux. 1985. Activity regulates the level of acetylcholine receptor α-subunit mRNA in cultured chick myotubes. Proc. Natl. Acad. Sci. USA. 82:4558-4562.
66. Laufer, R., and J.P. Changeux. 1989. Activity-dependent regulation of gene expression in muscle and neuronal cells. Mol. Neurobiol. 3:1-53.
67. Mossman, S., A. Vincent, and J. Newsom-Davis. 1986. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet. 1:116-119.
68. Engel, A.G., and G. Fumagalli. 1982. Mechanisms of aetylcholine receptor loss from the neuromuscular junction. Ciba Found. Symp. 90:197-224.
69. Altiok, N., S. Altiok, and J.P. Changeux. 1997. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity. EMBO (Eur. Mol. Biol. Organ.) J. 16:717-725.
70. Bencherif, M., and R.J. Lukas. 1993. Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: a possible functional role of the cytoskeleton. J. Neurochem. 61:852-864.
71. Hill, J.A., Jr. 1992. Nicotinic receptor-associated 43K protein and progressive stabilization of the postsynaptic membrane. Mol. Neurobiol. 6:1-17.
72. Fuhrer, C., and Z.W. Hall. 1996. Functional interaction of Src family kinases with the acetylcholine receptor in C2 myotubes. J. Biol. Chem. 13:32474-32481.
73. Flynn, D.C., T.H. Leu, A.B. Reynolds, and J.T. Parsons. 1993. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate. Mol. Cell. Biol. 13:7892-7900.